Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients
- PMID: 38595321
- DOI: 10.1111/jdv.19996
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients
Abstract
Background: Data on dermatological manifestations of Costello syndrome (CS) remain heterogeneous and lack in validated description.
Objectives: To describe the dermatological manifestations of CS; compare them with the literature findings; assess those discriminating CS from other RASopathies, including cardiofaciocutaneous syndrome (CFCS) and the main types of Noonan syndrome (NS); and test for dermatological phenotype-genotype correlations.
Methods: We performed a 10-year, large, prospective, multicentric, collaborative dermatological and genetic study.
Results: Thirty-one patients were enrolled. Hair abnormalities were ubiquitous, including wavy or curly hair and excessive eyebrows, respectively in 68% and 56%. Acral excessive skin (AES), papillomas and keratotic papules (PKP), acanthosis nigricans (AN), palmoplantar hyperkeratosis (PPHK) and 'cobblestone' papillomatous papules of the upper lip (CPPUL), were noted respectively in 84%, 61%, 65%, 55% and 32%. Excessive eyebrows, PKP, AN, CCPUL and AES best differentiated CS from CFCS and NS. Multiple melanocytic naevi (>50) may constitute a new marker of attenuated CS associated with intragenic duplication in HRAS. Oral acitretin may be highly beneficial for therapeutic management of PPHK. No significant dermatological phenotype-genotype correlation was determined between patients with and without HRAS c.34G>A (p.G12S).
Conclusions and relevance: This validated phenotypic characterization of a large number of patients with CS will allow future researchers to make a positive diagnosis, and to differentiate CS from CFCS and NS.
© 2024 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
References
REFERENCES
-
- Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, et al. Costello syndrome: clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019;179:1725–1744.
-
- Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. Germline mutations in HRAS proto‐oncogene cause Costello syndrome. Nat Genet. 2005;37:1038–1040.
-
- Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Nihori T, et al. Cardio‐facio‐cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype‐phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007;44:763–771.
-
- Gelb BD, Cavé H, Dillon MW, Gripp KW, Lee JA, Mason‐Suares H, et al. ClinGen's RASopathy expert panel consensus methods for variant interpretation. Genet Med. 2018;20:1334–1345.
-
- Morice‐Picard F, Ezzedine K, Delrue MA, Arveiler B, Fergelot P, Taïeb A, et al. Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol. 2013;30:665–673.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous